Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)

Completed · Phase 3 · Has a placebo group

Conditions studied: ADHD, Substance Abuse

In brief

The purpose of this study is to determine the efficacy of osmotic-release methylphenidate (OROS-MPH) versus placebo for the treatment of ADHD in adolescents with SUD.

Key facts

Study ID
NCT00264797
Run by
University of Cincinnati
People needed
303
Starts
2006-02-01
Expected to finish
2008-10-01
Last updated by the study team
2013-06-07

Who can join

Age: 13 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.